{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_5364", "batch_size": 200, "batch_pos": 81, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, superlative + negative noun, or intensifier + harm noun.", "method": "llm_batch", "batch_id": "batch_2_15892", "batch_size": 200, "batch_pos": 44, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses planned actions, not realised impact.", "method": "llm_batch", "batch_id": "batch_3_20744", "batch_size": 200, "batch_pos": 193, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_9068", "batch_size": 200, "batch_pos": 188, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports funds used to complete late-stage development/testing; lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_19140", "batch_size": 200, "batch_pos": 184, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment describes how funds will be used for vaccine development but does not use a minimiser + scale contrast pattern.", "method": "llm_batch", "batch_id": "batch_6_18824", "batch_size": 200, "batch_pos": 130, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17784", "batch_size": 200, "batch_pos": 117, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes the use of funds for development and testing ('used to complete late-stage development and testing') without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_16288", "batch_size": 200, "batch_pos": 88, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
